Evidence map›Paper›PMID 42614286›Full record

ArticleFrontiers in microbiology2026

Clinical and molecular epidemiology of

Meihong Wang, Liping Yu, Lisi Zheng, Xiajing Bi, Xiaobei Xu, Haiying Fang, Tao Lv, Yunbo Chen

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Meihong Wang *Department of Laboratory Medicine, Chun'an County hospital of Traditional Chinese Medicine, Hangzhou, China.
Liping Yu *Department of Laboratory Medicine, Chun'an County hospital of Traditional Chinese Medicine, Hangzhou, China.
Lisi ZhengState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Xiajing BiDepartment of Nursing, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Xiaobei XuDepartment of Laboratory Medicine, Chun'an County hospital of Traditional Chinese Medicine, Hangzhou, China.
Haiying FangDepartment of Laboratory Medicine, Chun'an County hospital of Traditional Chinese Medicine, Hangzhou, China.
Tao LvState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yunbo ChenState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: Between January and December 2025, we conducted a genomic epidemiology study of Results: In total, 50 (3.8%) toxigenic Conclusions: This study provides insight into the molecular epidemiology and antimicrobial resistance characteristics of toxigenic

Indexed as

antibiotic resistanceClostridioides difficile infectionmolecular epidemiologytransmissionwhole genome sequencing

Identifiers

PMID42614286
PMCPMC13481431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.